Sirius XM Holdings Inc vs Tempus AI — how do they compare? Sirius XM Holdings Inc trades at $26.92 (market cap $8.87B), while Tempus AI trades at $70.4 (market cap $12.58B). The key difference: Tempus AI is the larger of the two by market cap, and Sirius XM Holdings Inc pays a 4.1% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold Sirius XM Holdings Inc for 102 Days and Tempus AI for 22 Days on average.
| SIRI | TEM | |
|---|---|---|
Market Cap | $8.87B | $12.58B |
Volume | 4,324,672 | 7,444,569 |
Sector | Media | Broad Market / Factor |
52-Week High | $32.59 | $99.28 |
52-Week Low | $19.92 | $41.55 |
Typical Hold Time | 102 Days | 22 Days |
Enterprise Value | $18.16B | $13.21B |
Dividend Yield | 4.1% | — |
Signals from Pluang's Aura AI — not financial advice
SIRI trades at $25.95, down 1.56% with a bearish technical signal. The company shows mixed fundamentals with a P/E of 10.57 and P/B of 0.75 indicating potential undervaluation, but recent earnings misses and a significant net loss in 2024 raise concerns. Positive cash flow growth and a 62.5% analyst buy rating provide support, while the YouTube partnership offers growth potential.
The stock presents a value opportunity with upside to the $34.43 consensus target, but faces execution risks from subscription pressure and high debt. Recent institutional buying and management's focus on cash flow growth are positive catalysts, though technical weakness and competitive threats warrant caution for near-term investors.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite recent weakness. The company reported Q2 2026 revenue growth of 22% year-over-year and beat EPS estimates for three consecutive quarters, though it remains unprofitable with a net income margin of -17.77%. Recent positive developments include FDA clearance for its ECG-MR AI product and expanded data licensing agreements, fueling investor optimism in the healthtech sector.
The investment outlook is cautiously optimistic, driven by strong analyst support (64% buy ratings) and a consensus price target of $72.60, implying modest upside. Key opportunities include accelerating adoption of AI-powered diagnostics and strategic acquisitions, but risks persist from persistent cash burn, insider selling, and intense competition in the precision medicine space.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
SiriusXM Holdings is now composed of two businesses: SiriusXM and Pandora. SiriusXM transmits music, talk shows, sports, and news via its two satellite radio networks, primarily to consumers in vehicles who pay a subscription fee. The firm's radios come preinstalled on a wide range of light vehicles in the U.S. and Canada. The firm acquired Pandora Media in February 2019 via an all-stock transaction. Pandora is a streaming music platform that offers an ad-supported radio option and a paid on-demand service. Liberty Media owns 80% of SiriusXM, traded through its Liberty SiriusXM Group tracking stock.
Read more on SIRI →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →